Hormonal and Metabolic Consequences of Sleep Disorders in Young Obese Patients
NCT ID: NCT00716222
Last Updated: 2009-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
70 participants
OBSERVATIONAL
2008-05-31
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Sleep Deprivation on Food Intake and Motor Activity in Man
NCT00986492
Sleep Deprivation and Energy Balance
NCT00935402
Effect of Sleep Restriction on Metabolic Disturbances Caused by Overfeeding
NCT02075723
Sleep Deprivation and Energy Balance
NCT01334788
The Impact of Sleep Restriction on Gastric Emptying, Appetite and Energy Intake
NCT05953285
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Obese adolescent and young adult with sleep disorder
No interventions assigned to this group
2
Obese adolescent and young adult without sleep disorder
No interventions assigned to this group
3
Lean adolescent and young adult with sleep disorder
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \> 30 kg/m2 (If adolescents aged under 18 years: BMI equivalent to a BMI for age and sex to a BMI of 30, according to the Cole et al. obesity criteria).
Exclusion Criteria
* Liver disease
* Chronic inflammatory disease
* Endocrine disease
* Use of drugs that alter the sensitivity of insulin
13 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cliniques universitaires Saint-Luc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veronique Beauloye, PhD
Role: PRINCIPAL_INVESTIGATOR
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cliniques Universitaires Saint Luc
Brussels, Brussels Capital, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B40320084032
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.